Ignite Creation Date:
2024-05-06 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05191888
Status:
RECRUITING
Last Update Posted:
2022-01-14
First Post:
2021-12-28
Brief Title:
14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy
Sponsor:
Kaohsiung Medical University
Organization:
Kaohsiung Medical University
Organization Data
Organization:
Kaohsiung Medical University
Class:
OTHER
Study ID:
KMUHIRB-FI-20210136
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kaohsiung Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
DENG-CHYANG WU
Responsible Party Title:
Clinical Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Kaohsiung Medical University
Old Name:
None
Old Organization:
None